Cell and Gene Therapy Market Size, Share, Growth Analysis, By Therapy Type (Cell Therapy, Gene Therapy), By Therapeutic class (Cardiovascular Disease, Cancer), By Delivery Method, By End-Users, By Region - Industry Forecast 2024-2031

North America is projected to account for a dominant share of the global cell and gene therapy market owing to high investments in medical R&D in this region. High healthcare expenditure, presence of a developed healthcare infrastructure, and rising acceptance of novel therapies are key factors that contribute to the dominance of this region. The United States is slated to be the leading market for cell and gene therapy providers looking to dominate North American market. Supportive government initiatives and funding to boost medical research will also help promote market development in this region.

Meanwhile, the demand for cell and gene therapy in the Asia Pacific region is projected to increase at a robust pace across the study period and beyond. Increasing awareness regarding healthcare and growing prevalence of chronic diseases are primarily boosting the demand for cell and gene therapy in this region. Increasing geriatric population, rising healthcare expenditure, and growing awareness regarding benefits of novel therapies are also playing a crucial role in promoting cell and gene therapy market growth in this region. China, India, and Japan will continue to remain the top markets for cell and gene therapy companies operating in this region.